PI
CBPO

PEAK6 Investments’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

PEAK6 Investments’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-8,125
Closed -$665K – 4976
2018
Q4 		$617K Buy
+8,125
New +$598K ﹤0.01% 2183

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PEAK6 Investments's CBPO Position: Q1 2019 in Review

PEAK6 Investments sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2019, closing a stake of 8,125 shares — an estimated $665K sold.

PEAK6 Investments first reported a position in CBPO in Q4 2018 and held it in 1 quarter. The position peaked at $617K in Q4 2018. 69 funds tracked by Wall St. Rank hold CBPO as of Q1 2019.

  • PEAK6 Investments reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
  • PEAK6 Investments sold 8,125 China Biologic Products Holdings, Inc. shares in Q1 2019, an estimated $665K.
  • PEAK6 Investments first reported a position in China Biologic Products Holdings, Inc. in Q4 2018 and held it in 1 quarter.
  • PEAK6 Investments's China Biologic Products Holdings, Inc. position peaked at $617K in Q4 2018.
  • 69 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2019.

Based on PEAK6 Investments's 13F filing for Q1 2019, filed 15 May 2019.